SPH Publication of materials for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for 15 January 2027
Sofia, Bulgaria, November 18, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of “Sopharma” AD (SFA: “BSE“ AD, SPH: Warsaw Stock Exchange) presents the following materials on the agenda of EGM convened for January 15, 2027 and in the absence of a quorum on this date – for February 05, 2027, to the attention of shareholders, which will be available on the website of Extri News (www.x3news.com), in the FSC system, on the Company's website www.sopharmagroup.com and on the website www.investor.bg, as well as in hard copy at the address of the Company:
| Data | Tytuł | Kurs | Zmiana |
|---|
2026-11-18 | SPH Publication of materials for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for 15 January 2027 | 13,45 | -2,23 |
2026-11-02 | SPH Minutes of meeting from an Extraordinary General Meeting of shareholders of "Sopharma" AD held on October 30, 2026 | 14,20 | 0,00 |
2026-10-30 | SPH Notification for dividend payment | 14,30 | -5,59 |
2026-10-30 | SPH Individual financial report according to IFRS as at 30 September 2026 | 14,30 | -5,59 |
2026-10-29 | SPH Invitation to convene a General Meeting of Warrant holders (GMWH) of “Sopharma” AD with ISIN BG9200003259 | 14,30 | 0,00 |
2026-10-29 | SPH Invitation to convene a General Meeting of Warrant holders (GMWH) of “Sopharma” AD with ISIN BG9200004257 | 13,80 | +3,62 |
2026-10-29 | SPH Invitation to convene a General Meeting of Warrant holders (GMWH) of “Sopharma” AD with ISIN BG9200001253 | 13,80 | +3,62 |
2026-10-20 | SPH Preliminary sales revenue data for September 2026 | 12,50 | -4,00 |
2026-10-15 | SPH Correction of Notification from "Kaliman RT" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD on 16.09.2026 | 11,50 | 0,00 |
2026-10-15 | SPH Correction of Notification from "Kaliman RT" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD on 11.09.2026 | 11,50 | 0,00 |